Rakovina Therapeutics Showcases Potent AI-Developed ATR Inhibitors with CNS Penetrance at AACR-NCI-EORTC International Conference

Rakovina Therapeutics Inc. (“Rakovina” or the “Company”) (TSX-V: RKV)(FSE: 7JO0) is pleased to announce the successful presentation of new data at ...

Rakovina Therapeutics to Present New Data Highlighting Novel ATR Inhibitor with CNS Penetration at the AACR-NCI-EORTC International Conference

Rakovina Therapeutics Inc. (“Rakovina” or the “Company”) (TSX-V: RKV, FSE: 7JO0), a biopharmaceutical company advancing ...
Ophthalmology Times

Ophthalmic innovation by the decades: The 2010s

From the 2010s to the present, the existing technologies in the clinic and operating room have been improved with the goals ...
C&EN

Genetically Encoded Cell Fate Reporter System for Multiplex Single-Cell Detection of DNA and Mitochondrial Damage

Article subjects are automatically applied from the ACS Subject Taxonomy and describe the scientific concepts and themes of the article. The expression vector for the truncated version of h53BP1 with ...